Study suggests COVID-19 vaccine acceptance on the rise in UK

A team of researchers in the UK – namely, Ben Ansell (Oxford), Martin W. Bauer (LSE), Jane Gingrich (Oxford), and Jack Stilgoe (UCL) – recently conducted a two-wave survey on the hesitancy of individuals to receive coronavirus disease 2019 (COVID-19) vaccination.

The first survey included 1642 responders and took place between September 30 to October 1, 2020. The second survey was conducted over the week commencing February 1, 2021, and had fewer respondents. During the second wave, the scientists reached out to the same group of respondents as the first wave. However, only 1219 responses were received, with a retention rate of 74%.

The study included participants who were 'likely' and 'very likely' to take the vaccine and also individuals who had already been vaccinated. The researchers categorized participant responses into different groups such as age, political factors, ethnicity, etc.

The researchers highlight some crucial points related to the mood of the British public toward COVID-19 vaccines. Some of the key observations in each category during wave one and wave two survey are discussed below:

Vaccine Acceptance

The researchers reported that enthusiasm or keenness to take the COVID-19 vaccine has significantly increased since October 1, 2020. The ratio of participants who were 'very likely' to take the vaccine has increased from half to over three-quarters. This survey reported that the overall willingness to take the vaccine has increased from 78% to 87%.

One limitation of this survey is that it does not consider people in nursing homes and has fewer respondents belonging to the older age group (above 80 years). However, 13% of the candidates associated with this survey had received the vaccine in the first week of February.

Vaccine Refusal

Around 7% stated that they were ‘very unlikely' to take the vaccine. There was no shift in this percentage even after the second wave survey. Additionally, the majority of participants who were previously reluctant or 'didn’t know' if they will take the vaccine changed their mind, indicating that they were now 'very likely' to do so.

Demographics

The second wave survey report suggested no strong gender difference regarding the keenness to take the vaccine. However, the first wave report indicated that women were substantially more reluctant to be vaccinated. Lower-income people were found to be less keen to take the vaccine. A weak correlation was found between education and willingness to take the vaccine. Participants whose education ended at 18yrs of age were reported to be the most willing group. In the first wave survey, vaccine hesitancy was more prevalent in ethnic minority communities, which gradually shifted by the second-wave survey.

Political Factors

Participants who did not vote in 2019 were found to be less likely to accept vaccines than people who voted, the study found. Researchers observed that vaccine acceptance was low among Brexit Party and Green Party supporters. Further, supporters of the Reform UK party were substantially less inclined to take the vaccine. Scotting National Party supporters who took part in this survey showed a strong willingness to take the vaccine.

Vaccine Policy Approval

This survey found a 69% approval of the speed with which the policymakers and regulators approved vaccines, 74% approval on the manner of rolling out vaccines, and 78% on the strategy that elderly and health workers should be vaccinated first. Only 41% approved the strategy of delaying the second dose of the vaccine.

Gender difference played no role in accepting policies concerning the vaccine or vaccination. The percentage of approval was higher among the elderly, and political factors also played a significant role. However, according to the study’s findings, ethnicity, education, and income had a minimal effect on the vaccine policy approval.

Source:
Dr. Priyom Bose

Written by

Dr. Priyom Bose

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bose, Priyom. (2021, March 15). Study suggests COVID-19 vaccine acceptance on the rise in UK. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20210315/Study-suggests-COVID-19-vaccine-acceptance-on-the-rise-in-UK.aspx.

  • MLA

    Bose, Priyom. "Study suggests COVID-19 vaccine acceptance on the rise in UK". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20210315/Study-suggests-COVID-19-vaccine-acceptance-on-the-rise-in-UK.aspx>.

  • Chicago

    Bose, Priyom. "Study suggests COVID-19 vaccine acceptance on the rise in UK". News-Medical. https://www.news-medical.net/news/20210315/Study-suggests-COVID-19-vaccine-acceptance-on-the-rise-in-UK.aspx. (accessed November 24, 2024).

  • Harvard

    Bose, Priyom. 2021. Study suggests COVID-19 vaccine acceptance on the rise in UK. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20210315/Study-suggests-COVID-19-vaccine-acceptance-on-the-rise-in-UK.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses